Myriad Asset Management’s Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share APGB.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding APGB.WS
AMH
SAMU
PF
RCM
HCM
GRIM
AC
LP
SRCM
Myriad Asset Management's APGB.WS Position: Q1 2022 in Review
Myriad Asset Management held its Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (APGB.WS) position steady in Q1 2022 at 30,000 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #78.
Myriad Asset Management first reported a position in APGB.WS in Q2 2021 and has held it in 4 quarters since. The position peaked at $39K in Q2 2021. 55 funds tracked by Wall St. Rank hold APGB.WS as of Q1 2022.
- Myriad Asset Management held 30,000 shares of Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share worth $17K as of Q1 2022.
- Myriad Asset Management left its Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share share count unchanged in Q1 2022.
- Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share made up ﹤0.01% of Myriad Asset Management's portfolio in Q1 2022, its #78 holding.
- Myriad Asset Management first reported a position in Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share in Q2 2021 and has held it in 4 quarters since.
- Myriad Asset Management's Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position peaked at $39K in Q2 2021.
- 55 funds tracked by Wall St. Rank held Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share as of Q1 2022.
Based on Myriad Asset Management's 13F filing for Q1 2022, filed 16 May 2022.